Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 14Gastrointestinal 7Sarcoma 2Head & Neck 2Genitourinary 2Tumor-Agnostic 1Endocrine 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 150Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Ferrosoferric Oxide × Genitourinary × Clear all
NCT04369560 2025-12-17

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
42 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00087347 2013-05-14

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Massachusetts General Hospital

Completed
14 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡